Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic period

Research output: Contribution to journalReview articlepeer-review


  • Rosanna Cannatelli
  • Nunzia Labarile
  • Ren Mao
  • Remo Panaccione
  • Silvio Danese
  • Gursimran S Kochhar
  • Subrata Ghosh
  • Bo Shen

Colleges, School and Institutes


The coronavirus disease 2019 (COVID-19) pandemic is changing the management of many chronic diseases, including that of patients with inflammatory bowel diseases (IBD). In particular, the performance of routine endoscopy is temporarily suspended, and only emergency endoscopy is allowed in many countries where severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread. We highlight different scenarios in which endoscopy should still be performed urgently in patients with IBD, as well as recommendations regarding the use of personal protective equipment. We suggest a pathway for performing safe endoscopy and discuss the potential risks of postponing endoscopy in IBD. Finally, we propose a post-pandemic plan for access to endoscopy.


Original languageEnglish
Pages (from-to)598-606
Number of pages9
JournalThe Lancet Gastroenterology and Hepatology
Issue number6
Early online date16 Apr 2020
Publication statusPublished - Jun 2020


  • Betacoronavirus, Coronavirus Infections/epidemiology, Endoscopy, Digestive System, Humans, Inflammatory Bowel Diseases/diagnosis, Pandemics, Pneumonia, Viral/epidemiology, Practice Guidelines as Topic